These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21372118)

  • 21. Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis.
    Novakova L; Axelsson M; Khademi M; Zetterberg H; Blennow K; Malmeström C; Piehl F; Olsson T; Lycke J
    J Neurochem; 2017 Apr; 141(2):296-304. PubMed ID: 27787906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
    Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
    Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
    Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
    Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy.
    Ferreira D; Voevodskaya O; Imrell K; Stawiarz L; Spulber G; Wahlund LO; Hillert J; Westman E; Karrenbauer VD
    J Neuroimmunol; 2014 Sep; 274(1-2):149-54. PubMed ID: 24999245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal BAFF and Epstein-Barr virus-specific oligoclonal bands in multiple sclerosis and other inflammatory demyelinating neurological diseases.
    Franciotta D; Di Stefano AL; Jarius S; Zardini E; Tavazzi E; Ballerini C; Marchioni E; Bergamaschi R; Ceroni M
    J Neuroimmunol; 2011 Jan; 230(1-2):160-3. PubMed ID: 21109310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosis.
    Villar LM; Espiño M; Cavanillas ML; Roldán E; Urcelay E; de la Concha EG; Sádaba MC; Arroyo R; González-Porqué P; Alvarez-Cermeño JC
    Clin Immunol; 2010 Oct; 137(1):51-9. PubMed ID: 20621566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS).
    Brettschneider J; Czerwoniak A; Senel M; Fang L; Kassubek J; Pinkhardt E; Lauda F; Kapfer T; Jesse S; Lehmensiek V; Ludolph AC; Otto M; Tumani H
    PLoS One; 2010 Aug; 5(8):e11986. PubMed ID: 20700489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokines and intrathecal IgG synthesis in multiple sclerosis patients during clinical remission.
    Brandão CO; Ruocco HH; Farias Ados S; Oliveira C; Hallal-Longo DE; Mirandola SR; Oliveira EC; Cendes F; Damasceno BP; Santos LM
    Arq Neuropsiquiatr; 2005 Dec; 63(4):914-9. PubMed ID: 16400404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis.
    Burman J; Svenningsson A
    J Neuroimmunol; 2016 Mar; 292():40-4. PubMed ID: 26943957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic relevance of the C-X-C motif chemokine ligand 13 and interleukin-8 in predicting the transition from clinically isolated syndrome to multiple sclerosis.
    Klíčová K; Mareš J; Sobek O; Rous Z; Rous M; Raška M; Hartung HP
    Eur J Neurosci; 2024 Jun; 59(11):2955-2966. PubMed ID: 38453679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of cerebrospinal fluid levels of lateral olfactory tract usher substance (LOTUS) with disease activity in multiple sclerosis.
    Takahashi K; Kurihara Y; Suzuki Y; Goshima Y; Tanaka F; Takei K
    JAMA Neurol; 2015 Feb; 72(2):176-9. PubMed ID: 25437093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis.
    Axelsson M; Mattsson N; Malmeström C; Zetterberg H; Lycke J
    J Neuroimmunol; 2013 Nov; 264(1-2):100-5. PubMed ID: 24125567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant Humoral Immune Responses in Neurosyphilis: CXCL13/CXCR5 Play a Pivotal Role for B-Cell Recruitment to the Cerebrospinal Fluid.
    Yu Q; Cheng Y; Wang Y; Wang C; Lu H; Guan Z; Huang J; Gong W; Shi M; Ni L; Wu J; Peng R; Zhou P
    J Infect Dis; 2017 Sep; 216(5):534-544. PubMed ID: 28931218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.
    Castellazzi M; Contini C; Tamborino C; Fasolo F; Roversi G; Seraceni S; Rizzo R; Baldi E; Tola MR; Bellini T; Granieri E; Fainardi E
    J Neuroinflammation; 2014 Nov; 11():188. PubMed ID: 25391491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical relevance of antibodies against myelin oligodendrocyte glycoprotein in different clinical types of multiple sclerosis.
    Zadro I; Brinar V; Horvat G; Brinar M
    Clin Neurol Neurosurg; 2007 Jan; 109(1):23-6. PubMed ID: 16750597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wide Cytokine Analysis in Cerebrospinal Fluid at Diagnosis Identified CCL-3 as a Possible Prognostic Factor for Multiple Sclerosis.
    Puthenparampil M; Stropparo E; Zywicki S; Bovis F; Cazzola C; Federle L; Grassivaro F; Rinaldi F; Perini P; Sormani MP; Gallo P
    Front Immunol; 2020; 11():174. PubMed ID: 32194540
    [No Abstract]   [Full Text] [Related]  

  • 37. Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis.
    Koch M; Heersema D; Mostert J; Teelken A; De Keyser J
    Eur J Neurol; 2007 Jul; 14(7):797-800. PubMed ID: 17594338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing-remitting multiple sclerosis patients.
    Kalinowska-Łyszczarz A; Szczuciński A; Pawlak MA; Losy J
    J Neurol Sci; 2011 Jan; 300(1-2):81-5. PubMed ID: 20947098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Investigation of B-cell activating factor in serum and cerebrospinal fluid of patients with neuromyelitis optical].
    Yang F; Huang D; Wu W
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Mar; 35(3):380-3. PubMed ID: 25818784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis.
    Brettschneider J; Maier M; Arda S; Claus A; Süssmuth SD; Kassubek J; Tumani H
    Mult Scler; 2005 Jun; 11(3):261-5. PubMed ID: 15957504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.